By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – ImaGenes has received certification from Roche NimbleGen to provide services using the firm's comparative genomic hybridization array workflow from its headquarters in Berlin, Roche said today.

Roche noted that over the past six months ImaGenes has also been certified to offer its DNA methylation analysis and its ChIP-chip services, and that it is the first certified CGH provider in Europe.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.